Avanos Medical Inc.

NYSE: AVNS · Real-Time Price · USD
10.97
0.22 (2.05%)
At close: Aug 14, 2025, 3:59 PM
11.00
0.23%
After-hours: Aug 14, 2025, 06:24 PM EDT

Avanos Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
687.8M 673.3M 820M 744.6M
Cost of Revenue
306.5M 293.6M 370M 380.3M
Gross Profit
381.3M 379.7M 450M 364.3M
Operating Income
-396.2M 4.2M 74M 8.9M
Interest Income
5.1M 2.9M 1.2M 200K
Pretax Income
-403.3M -7.9M 65.2M 5.8M
Net Income
-392.1M -61.8M 50.5M 6.3M
Selling & General & Admin
318.5M 318.1M 341.9M 300.3M
Research & Development
26.2M 27.2M 30.6M 32.3M
Other Expenses
432.8M 30.2M 3.5M 22.8M
Operating Expenses
777.5M 375.5M 376M 355.4M
Interest Expense
12.2M 15M 10M 3.3M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
1.08B 669.1M 746M 735.7M
Income Tax Expense
-17M 2M 14.7M 600K
Shares Outstanding (Basic)
46M 46.6M 46.9M 48.1M
Shares Outstanding (Diluted)
46M 46.6M 47.3M 48.6M
EPS (Basic)
-8.53 -1.33 1.08 0.13
EPS (Diluted)
-8.53 -1.33 1.07 0.13
EBITDA
-345.6M 50.6M 77.8M 8.9M
EBIT
-391.1M 7.1M 36.7M -38.8M
Depreciation & Amortization
45.5M 46.1M 41.1M 38.3M